This work was supported by the Ligue Nationale Contre le Cancer(L.P.,Z.L.);China Scholarship Council(W.L.,L.D.);Italian Association for Cancer Research(IG17413)(S.P.);the French National Research Agency under the frame of the H2020 Era-Net EURONANOMED European Research projects“Target4Cancer”,“NANOGLIO”,“TARBRAINFECT”,“NAN4-TUM”(L.P.),and H2020 NMBP“SAFE-N-MEDTECH”(L.P.);This article is based upon work from COST Action CA 17140“Cancer Nanomedicine from the Bench to the Bedside”supported by COST(European Cooperation in Science and Technology).
Gene therapy using small interfering RNA(siRNA)is emerging as a novel therapeutic approach to treat various diseases.However,safe and efficient siRNA delivery still constitutes the major obstacle for clinical implemen...
This work was supported by the National Natural Science Foundation of China(No.21575088);the Natural Science Foundation of Shanghai(No.19ZR1474200).
BCL-2 gene as well as its products is recognized as a promising target for the molecular targeted therapy of tumors.However,due to certain defense measures of tumor cells,the therapeutic effect based on the gene silen...
Ribonucleic acids (RNAs) possess great therapeutic potential and can be used to treat a variety of diseases. The unique biophysical properties of RNAs, such as high molecular weight, negative charge, hydrophilicity,...
Small interfering RNA (siRNA) is an attractive therapeutic candidate for sequence- specific gene silencing to treat incurable diseases using small molecule drugs. However, its efficient intracellular delivery has re...
RNA plays important roles as a gene-silencing agent, a therapeutic agent for clinical treatment, and in the differentiation, proliferation, and development of cells. However, RNA is very difficult to work with due to ...
This work was supported by the National Natural Science Foundation of China (NSFC) (61107017, 81301318), the Start-up grant (M4080141.040) from Nanyang Technological University, Tier 1 Academic Research Funds (M4010360.040 RG29/10) from Singapore Ministry of Education and partially from the Singapore Ministry of Education under a Tier 2 Research Grant MOE2010-T2-2-010 (4020020.040 ARC2/11) and the grant from the Shenzhen Basic Research Project (JC201005280391A)
We have developed aggregation-induced emission (AIE) dye loaded polymer nanoparticles with deep-red emission for siRNA delivery to pancreatic cancer cells. Two US Food and Drug Administration (FDA) approved surfac...